跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Inactivated Quadrivalent Influenza Vaccine (Split Virion) - TGA Drug Approval Details
Approvals
/
TGA
/
Inactivated Quadrivalent Influenza Vaccine (Split Virion)
Approved
STANDARD
Inactivated Quadrivalent Influenza Vaccine (Split Virion)
Seqirus Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
2fb50df9e88f95ce
Company
Seqirus Pty Ltd
Type
Standard
Approval Details
Approval Id
2fb50df9e88f95ce
Product Name
Inactivated Quadrivalent Influenza Vaccine (Split Virion)
Artg Id
391067
Artg Name
Inactivated Quadrivalent Influenza Vaccine (Split Virion)
Sponsor
Seqirus Pty Ltd
Company Detail Path
/organization/seqirus-pty-ltd
Artg Date
2022-06-21
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LIE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
2fb50df9e88f95ce
Type
Standard
Back to TGA Approvals
